Dr. Ardaman Shergill, MD
Claim this profileUniversity of Chicago Comprehensive Cancer Center
Studies Colorectal Cancer
Studies Adenocarcinoma
23 reported clinical trials
61 drugs studied
Area of expertise
1Colorectal Cancer
Stage IV
Stage III
BRAF negative
2Adenocarcinoma
Stage IV
Stage III
HER2 positive
Affiliated Hospitals
Clinical Trials Ardaman Shergill, MD is currently running
BRAF-Targeted Therapy
for Colon Cancer
This phase II/III trial compares treatment with encorafenib and cetuximab to usual care (patient observation) for reducing the chance of cancer recurrence after standard surgery and chemotherapy in patients with BRAF-mutated stage IIB-III colon cancer. Encorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Cetuximab is in a class of medications called monoclonal antibodies. It binds to a protein called EGFR, which is found on some types of tumor cells. This may help keep tumor cells from growing. Giving encorafenib and cetuximab after standard surgery and chemotherapy may be more effective at reducing the chance of cancer recurrence compared to the usual patient observation.
Recruiting1 award Phase 2 & 3
Atezolizumab + Chemotherapy
for Neuroendocrine Carcinoma
This trial is testing a new treatment combining an immune-boosting drug with standard chemotherapy for patients with a specific type of aggressive cancer that has spread. The goal is to help the immune system fight the cancer and use chemotherapy to kill cancer cells.
Recruiting1 award Phase 2 & 310 criteria
More about Ardaman Shergill, MD
Clinical Trial Related3 years of experience running clinical trials · Led 23 trials as a Principal Investigator · 12 Active Clinical TrialsTreatments Ardaman Shergill, MD has experience with
- Fluorouracil
- Irinotecan
- Cetuximab
- Atezolizumab
- Cisplatin
- Oxaliplatin
Breakdown of trials Ardaman Shergill, MD has run
Colorectal Cancer
Adenocarcinoma
Cancer
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ardaman Shergill, MD specialize in?
Ardaman Shergill, MD focuses on Colorectal Cancer and Adenocarcinoma. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are Stage III.
Is Ardaman Shergill, MD currently recruiting for clinical trials?
Yes, Ardaman Shergill, MD is currently recruiting for 12 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Ardaman Shergill, MD has studied deeply?
Yes, Ardaman Shergill, MD has studied treatments such as Fluorouracil, Irinotecan, Cetuximab.
What is the best way to schedule an appointment with Ardaman Shergill, MD?
Apply for one of the trials that Ardaman Shergill, MD is conducting.
What is the office address of Ardaman Shergill, MD?
The office of Ardaman Shergill, MD is located at: University of Chicago Comprehensive Cancer Center, Chicago, Illinois 60637 United States. This is the address for their practice at the University of Chicago Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.